Dr. Ross is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N. St. Clair St., Galter 20-250
Chicago, IL 60611Phone+1 312-695-8146
Summary
- Dr. Ross is a surgeon scientist who specializes in urology and urologic oncology and is a nationally recognized expert in prostate cancer. His research efforts focus on the development, testing and implementation of novel diagnostics and therapeutics with a goal of reducing the suffering from prostate cancer. Clinically, Dr. Ross performs prostate cancer screening, prostate biopsy (including MRI-fusion biopsy), active surveillance, robotic prostatectomy, open radical prostatectomy, and ablative therapies of the prostate. Prior to joining the Feinberg School of Medicine, Dr. Ross served as director of the Johns Hopkins Urology Prostate Cancer Program, the executive medical director of the Mary Crowley Cancer Research Center, and an associate chair of the US Oncology Genitourinary Research Committee.
Education & Training
Johns Hopkins UniversityResidency, Urology, 2006 - 2012- Johns Hopkins University School of MedicineClass of 2006
Certifications & Licensure
IL State Medical License 2020 - 2026
IN State Medical License 2024 - 2025
TX State Medical License 2017 - 2025
WI State Medical License 2024 - 2025
DC State Medical License 2024 - 2024
MD State Medical License 2010 - 2019- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance Start of enrollment: 2023 Aug 07
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 2 citationsTestosterone recovery after androgen deprivation therapy.Austin Y Ho, Eric V Li, Richard Bennett 4th, Chalairat Suk-Ouichai, Sai Kaushik Shankar Ramesh Kumar
Urologic Oncology. 2025-01-01 - Contemporary Diagnosis of Very Low-risk Prostate Cancer in a Multihospital Health Care System.Richard Bennett 4th, Eric V Li, Austin Y Ho, Jonathan Aguiar, Ashorne K Mahenthiran
European Urology Oncology. 2024-12-01 - Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate.Eric V Li, Matthew S Lee, Jenny Guo, Nicholas Dean, Sai Kumar
The Prostate. 2024-12-01
Journal Articles
- Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate CancerEmmanuel S Antonarakis, Ashley E Ross, Michael A Gorin, Samuel R Denmeade, Channing J Paller, Kenneth J Pienta, Mario A Eisenberger, JAMA Oncology
Authored Content
- Clinical and Genomic Characterization of Low–Prostate-Specific Antigen, High-Grade Prostate CancerFebruary 2018
Press Mentions
14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease UnderstandingMay 6th, 2024- Beyond Genomics: AI Informing Decision Making in Prostate Cancer – Ashley RossJanuary 22nd, 2023
- PSMA PET Imaging in Clinical Practice - Thomas Hope & Jeremie CalaisJanuary 3rd, 2023
- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ashley-ross
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
